ClinicalTrials.gg
CompletedNCT07862855PsyChAtUpdated Oct 7, 2026

PSYCHosocial Risk Factors of AThletes, Evaluation of a Questionnaire Constructed by CHATGPT

An observational study in Psychosocial Risk Factors, sponsored by University Hospital, Clermont-Ferrand. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by University Hospital, Clermont-Ferrand · Observational

Updated Oct 7, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
42
Sex
All
01

Study summary

The goal of this observational study was to assess themes generated by ChatGPT to help organize psychosocial risk factors in professional sport. These factors relate to aspects of athletes' working conditions and professional relationships that may affect their health. Academic experts and sport professionals evaluated the proposed themes and sub-themes. The main questions were :

  • How relevant, clearly worded, and comprehensive did experts find the proposed themes?
  • How relevant and clearly worded did experts find the proposed sub-themes?
  • Did experts' evaluations differ according to their characteristics? Participants completed an online questionnaire. They rated the proposals on scales from 0 to 10 and could provide written comments or suggest changes.
02

Conditions studied

  • Psychosocial Risk Factors

Keywords

  • Psychosocial risk factors
  • Mental health
  • Occupational health
  • Professional athletes
  • Artificial intelligence
03

In context

Psychological Well-Being

1,049 studies on the registry are indexed under Psychological Well-Being; 509 are open to participants now.

This study's enrollment of 42 is below the median of 200 across 146 observational studies indexed under Psychological Well-Being.

Browse Psychological Well-Being studies →

Lead sponsor

University Hospital, Clermont-Ferrand is the lead sponsor of 854 studies on the registry; 180 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Academic experts not working in professional sports clubs and sport professionals working within professional sports clubs. Academic experts included university professors and senior lecturers, medical doctors, nurses, osteopaths, and academic engineers. Sport professionals included head directors, coaching staff, sports physicians, sport psychologists, physiotherapists, strength and conditioning coaches, sport/data scientists, and scouts. A total of 83 experts (54 academic experts and 29 sport professionals) were contacted through individual email invitations.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Membership in either of the following two categories :

Academic experts not working in professional sports clubs: university professors, university senior lecturers, medical doctors, nurses, osteopaths, or academic engineers in the fields described in the study.

Sport professionals working within professional sports clubs: head directors, coaching staff, sports physicians, sport psychologists, physiotherapists, strength and conditioning coaches, sport/data scientists, or scouts.

Exclusion criteria

Exclusion Criteria:

  • None.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
42 participants (actual)
Patient registry
No

Groups and cohorts

  • Expert panel

    Academic experts and sport professionals who completed a one-time online questionnaire evaluating AI-generated themes and sub-themes on psychosocial risk factors in professional athletes.

06

What researchers measure

Primary outcomes

  1. Expert ratings of AI-generated psychosocial risk factor themes

    Academic experts and sport professionals evaluated each of eight AI-generated psychosocial risk factor themes using a study-specific online questionnaire. Each theme was rated separately for relevance, quality of formulation, and exhaustiveness using numerical rating scales from 0 to 10. For relevance, 0 indicated "not relevant at all" and 10 "highly relevant". For quality of formulation, 0 indicated "incomprehensible" and 10 "fully comprehensible". For exhaustiveness, 0 indicated "not complete at all" and 10 "fully complete". Higher scores indicated more favorable evaluations of the corresponding dimension. Scores were summarized separately for each theme and dimension.

    Time frame: At baseline (single assessment; no follow-up).

Secondary outcomes

  1. Association between expert characteristics and theme ratings.

    Relevance of each of eight AI-generated psychosocial risk factor themes was assessed using a study-specific online questionnaire on a numerical rating scale from 0 ("not relevant at all") to 10 ("highly relevant"). Higher scores indicated greater perceived relevance. Associations between relevance scores and expert characteristics (age, sex, professional role, and highest competitive sport level achieved) were examined using separate multiple linear regression models for each theme. The outcome was the relevance score, expressed in scale points.

    Time frame: At baseline (single assessment; no follow-up).

  2. Association between expert characteristics and theme formulation scores.

    Quality of formulation of each of eight AI-generated psychosocial risk factor themes was assessed using a study-specific online questionnaire on a numerical rating scale from 0 ("incomprehensible") to 10 ("fully comprehensible"). Higher scores indicated greater comprehensibility. Associations between formulation scores and expert characteristics (age, sex, professional role, and highest competitive sport level achieved) were examined using multiple linear regression models for each theme. The outcome was the formulation score, expressed in scale points.

    Time frame: At baseline (single assessment; no follow-up).

  3. Association between expert characteristics and theme exhaustiveness scores.

    Exhaustiveness of each of eight AI-generated psychosocial risk factor themes was assessed using a study-specific online questionnaire on a numerical rating scale from 0 ("not complete at all") to 10 ("fully complete"). Higher scores indicated greater perceived completeness. Associations between exhaustiveness scores and expert characteristics (age, sex, professional role, and highest competitive sport level achieved) were examined using multiple linear regression models for each theme. The outcome was the exhaustiveness score, expressed in scale points.

    Time frame: At baseline (single assessment; no follow-up).

07

Study locations

1 site
  • CHU de Clermont-Ferrand
    Clermont-Ferrand, France
08

References and documents

Individual participant data

Plan to share: No — There is no plan to share individual participant data.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07862855
Responsible party
Sponsor
First posted
Oct 7, 2026
Start date
Dec 27, 2024
Primary completion
Feb 26, 2025
Completion
Feb 26, 2025
Last update
Oct 7, 2026

Study contacts

Frédéric Dutheil
principal investigator · University Hospital, Clermont-Ferrand

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion